273 followers
RT @DogICUma: #SPLITtrial http://t.co/bT0mvRXiD4 0.9% saline vs. PlasmaLyte AKI risk same including for the high APACHE patients who got mo…
RT @DogICUma: #SPLITtrial http://t.co/bT0mvRXiD4 0.9% saline vs. PlasmaLyte AKI risk same including for the high APACHE patients who got mo…
T3g. However, in the SPLIT randomized clinical trial, there was no significant between-group difference for survival or risk of AKI and requirement of RRT .https://t.co/U2ksXPMHcw #NephJC https://t.co/n6hHboHHBl
RT @NephJC: T3g. However, in the SPLIT randomized clinical trial, there was no significant between-group difference for survival or risk o…
RT @NephJC: T3g. However, in the SPLIT randomized clinical trial, there was no significant between-group difference for survival or risk o…